These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11468234)

  • 21. Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry.
    Moon SY; Lim MK; Hong S; Jeon Y; Han M; Song SH; Lim KS; Yu KS; Jang IJ; Lee JW; Kang HJ; Song J
    Ann Lab Med; 2014 Jan; 34(1):7-14. PubMed ID: 24422189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine analysis of plasma busulfan by gas chromatography-mass fragmentography.
    Lai WK; Pang CP; Law LK; Wong R; Li CK; Yuen PM
    Clin Chem; 1998 Dec; 44(12):2506-10. PubMed ID: 9836718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring.
    Matar KM; Alshemmari SH; Refaat S; Anwar A
    Sci Rep; 2020 Jun; 10(1):8913. PubMed ID: 32488110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning.
    Punt AM; Langenhorst JB; Egas AC; Boelens JJ; van Kesteren C; van Maarseveen EM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():81-85. PubMed ID: 28445850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma indomethacin assay using high-performance liquid chromatography-electrospray-tandem mass spectrometry: application to therapeutic drug monitoring and pharmacokinetic studies.
    Taylor PJ; Jones CE; Dodds HM; Hogan NS; Johnson AG
    Ther Drug Monit; 1998 Dec; 20(6):691-6. PubMed ID: 9853990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol.
    Quernin MH; Poonkuzhali B; Médard Y; Dennison D; Srivastava A; Krishnamoorthy R; Chandy M; Jacqz-Aigrain E
    J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(1):147-52. PubMed ID: 10027646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance.
    Choong E; Uppugunduri CRS; Marino D; Kuntzinger M; Doffey-Lazeyras F; Lo Piccolo R; Chalandon Y; Peters C; Daali Y; Ansari M
    Ther Drug Monit; 2018 Feb; 40(1):84-92. PubMed ID: 29189665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method.
    Abe E; Alvarez JC
    Ther Drug Monit; 2006 Jun; 28(3):407-12. PubMed ID: 16778727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-performance liquid chromatographic-mass spectrometric assay of busulfan in serum and cerebrospinal fluid.
    Pichini S; Altieri I; Bacosi A; Di Carlo S; Zuccaro P; Iannetti P; Pacifici R
    J Chromatogr; 1992 Oct; 581(1):143-6. PubMed ID: 1429998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-MS/MS method development for quantification of busulfan in human plasma and its application in pharmacokinetic study.
    Nadella TR; Suryadevara V; Lankapalli SR; Mandava VB; Bandarupalli D
    J Pharm Biomed Anal; 2016 Feb; 120():168-74. PubMed ID: 26736033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
    Ming DS; Heathcote J
    J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan.
    Heggie JR; Wu M; Burns RB; Ng CS; Fung HC; Knight G; Barnett MJ; Spinelli JJ; Embree L
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):437-44. PubMed ID: 9188834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Müller C; Gehlen D; Blaich C; Prozeller D; Liss B; Streichert T; Wiesen MHJ
    Ther Drug Monit; 2017 Oct; 39(5):505-513. PubMed ID: 28742650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation.
    Slattery JT; Risler LJ
    Ther Drug Monit; 1998 Oct; 20(5):543-9. PubMed ID: 9780133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of serum amantadine by liquid chromatography-tandem mass spectrometry.
    Arndt T; Guessregen B; Hohl A; Reis J
    Clin Chim Acta; 2005 Sep; 359(1-2):125-31. PubMed ID: 15913590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Crommentuyn KM; Rosing H; Nan-Offeringa LG; Hillebrand MJ; Huitema AD; Beijnen JH
    J Mass Spectrom; 2003 Feb; 38(2):157-66. PubMed ID: 12577282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometry.
    Oechtering D; Boos J; Hempel G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):129-34. PubMed ID: 16725388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Plasma Busulfan.
    Garg U; Munar A; Clinton Frazee C
    Methods Mol Biol; 2024; 2737():133-140. PubMed ID: 38036817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring.
    De Gregori S; Tinelli C; Manzoni F; Bartoli A
    Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):155-159. PubMed ID: 33231835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.